ABIM Research Pathway
The Department of Medicine offers candidates with interest in a career as a physician scientist the opportunity to enter our ABIM Research Pathway. With approval of the American Board of Internal Medicine, residents may train in the clinical sciences and in clinical or biomedical research through the Research Pathway. This training leads to certification in internal medicine after two years of clinical training plus at least two years of research in the setting of a subspecialty fellowship. Special rules apply to each of the subspecialties with each requiring 6 or 7 years of training between internal medicine, fellowship and research.
Dr. Terry Watnick oversees the Research Pathway and ensures that each resident receives effective and close mentorship through both personal counseling and group meetings with all the trainees in the Pathway. Her expertise in mentoring young physicians and conducting her research of the biology of cystic kidney disease ensures that our trainees receive the comprehensive support they need to be successful while in the Pathway and in their future academic careers. Our chair, Dr. Stephen Davis, is highly supportive of the Research Pathway as a means to ensure a successful trajectory for a career in scientific investigation.
Residents and fellows in the Research Pathway are strongly encouraged to enter the PhD for Clinicians program during their research years. This program provides a rigorous, accelerated curriculum to train medical scientists for careers in basic or translational research. PhD's are awarded through the Graduate Program in Life Sciences. These programs include: Biochemistry, Molecular Medicine, Molecular Microbiology and Immunology, Neuroscience, Physical Therapy and Rehabilitative Science, Epidemiology, Gerontology and Toxicology. See the Ph.D. Program for Clinicians for more information.
We seek to recruit 2-3 residents each year into our Research Pathway and currently have several residents and fellows in the Pathway across various subspecialties. Their career goals and research interests are detailed below. All residents and fellows in the Pathway are either currently in or recent graduates of our residency program.
If you are interested in applying to the ABIM Research Pathway, see our Application Process to complete a Supplemental Application, which will allow you to elaborate on your research interests.
Also review the ABIM Requirements for this pathway for more information. If you are invited for an interview for the Research Pathway, you will have a more in-depth day-long visit with us. You will meet with Drs. Watnick and Wolfsthal, and with other faculty in internal medicine and your chosen subspecialty, thus giving you a comprehensive view of our clinical and research opportunities. We welcome your application for this track. If you have any questions, please email us at email@example.com.
Andrew Clerman, MD
BS, Cellular and Molecular Biology, Johns Hopkins University, 2006
MD, George Washington University School of Medicine and Health Sciences, 2011
Internal Medicine Residency, University of Maryland, 2011-2013
Fellowship, Pulmonary and Critical Care Medicine, University of Maryland, 2013 - present
Andrew completed his two years of Internal Medicine training with us in June 2013. He is now in his third year of fellowship in Pulmonary and Critical Care Medicine, and began a Ph.D. in Molecular Microbiology and Immunology in the Spring of 2015. He works in the lab of Dr. Sergei Atamas where he investigates the sub-cellular localization, proteolytic processing and differential expression of inflammatory cytokines in the context of idiopathic pulmonary fibrosis (IPF). He utilizes donated normal human lung tissue in his research and plans to do comparative studies with diseased tissue obtained through the University's Lung Transplant Program.
Anan Said, MD
BS, Neurobiology & Physiology, University of Maryland, College Park, 2006
MD, Howard University School of Medicine, 2011
Internal Medicine Residency, University of Maryland, 2011-2013
Fellowship, Gastroenterology and Hepatology, University of Maryland, 2013 - present
Anan completed his two years of internal medicine in our residency program in June 2013, and is now a third year fellow in the Division of Gastroenterology and Hepatology. His research interests are in determining the molecular pathogenesis of gastrointestinal cancers, with particular attention to different signaling pathways in colorectal cancer. He is currently studying how acetylcholine-induced activation of p38 mitogen-activated protein kinase (MAPK) plays a role in colon cancer cell progression and metastasis, while continuing his clinical training in GI.
Fariha Ramay, MD
BS, Biology and Economics (Summa cum laude), Union College, 2009
MBA in Healthcare Management, Union Graduate College, 2010
MD, Albany Medical College, 2013
Internal Medicine Residency, University of Maryland, 2013-2015
Fellowship, Gastroenterology and Hepatology, University of Maryland, 2015 - present
Fariha earned her Medical Degree with a Distinction in Bioethics at Albany Medical College in Albany, NY where she was awarded the Albert M. Yunich Prize, for excellence in Gastroenterology. She completed her internal medicine training in July 2015 and is currently a fellow in the Division of Gastroenterology and Hepatology. Her prior research examined procedural cost-effectiveness of minimally invasive endovascular revascularization versus surgical bypass revascularization using an amortized cost per day of patency model for patients with femoral-popliteal (FP) occlusive disease. She has also studied the diagnostic sufficiency of 22-gauge (G) Fine Needle Aspiration (FNA) and 22G biopsy needles (FNB) for Endoscopic Ultrasound (EUS)-guided sampling of solid pancreatic masses and abnormal-appearing lymph nodes. Her research interests include clinical research and healthcare resource utilization in gastroenterology, and outcomes research in Advanced Endoscopy. She is currently examining the efficacy of endoscopic ablation therapy in the management of Barrett's Esophagus-associated dysplasia and early adenocarcinoma.
Ameer Abutaleb, MD
BS, University of Maryland College Park, Electrical Engineering, 2009
MD, University of Maryland School of Medicine
Internal Medicine Residency, University of Maryland, 2014-2016
Fellowship, Gastroenterology and Hepatology, University of Maryland, Planned for 2016
Ameer received his Medical Degree from the University of Maryland School of Medicine. He has engaged in research with the Division of Gastroenterology and Hepatology for several years receiving the American Gastroenterological Association Eli and Edythe Broad Student Research Fellow award. He was also a Benjamin H. Kean Fellow of the American Society of Tropical Medicine and Hygiene and a Howard Hughes Medical Institute Research Fellow. His work has included study of the role of acetylcholine induced activation of p38 mitogen activated protein kinase in human colon cancer cells. Ameer has accumulated 5 peer-reviewed articles and several abstracts and oral presentations. His research interests included non-alcoholic fatty liver disease and hepatitis C disease.
Meagan E. Deming, MD, PhD
BA, Swarthmore College, 2006
PhD, Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, 2013
Internal Medicine Residency, University of Maryland, 2015-2017
Fellowship, Infectious Diseases, University of Maryland, Planned for 2017.
Meagan earned her Medical Degree and PhD from the University of North Carolina where she defended her thesis on Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). She has authored several peer-reviewed papers in major journals (Journal of Virology, Current Opinion in Virology) and presented her research at regional and international meetings. Coming to the University of Maryland was an ideal move for her career development. After completing her residency training in internal medicine, Meagan will launch her fellowship in infectious diseases. She plans to focus her research on respiratory viruses and build her lab as a physician scientist in our Institute for Human Virology.